Abstract

Recently there has been considerable debate regarding the importance of post-prandial glucose (PPG) levels in patients with diabetes. Previously, therapeutic intervention focused on optimizing overall glycemic control as assessed by glycated hemoglobin (HbA1c) levels, with a strong emphasis on fasting plasma glucose (FPG). There was concern in some quarters that setting PPG goals could be unrealistic and even unsafe because they carry an increased risk for hypoglycemia. 1 However, a growing body of evidence suggests that reducing PPG is as important, or even more important, for achieving HbA1c goals.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call